Monteverde & Associates Launches Investigations Into Four Corporate Mergers

The investigations focus on potential fiduciary breaches during ongoing consolidation deals. For NCS Multistage Holdings (NASDAQ: NCSM) and its merger with Weatherford International, the firm is scrutinizing a deal that offers shareholders a mix of Weatherford stock or a combination of cash and stock equivalents. Simultaneously, the firm is examining the sale of PSB Holdings (OTCQX: PSBQ) to Bank First Corporation, where shareholders are slated to receive 0.3470 shares of Bank First stock per share held.

Legal review also extends to the biotechnology sector. The firm is investigating the merger between Standard Biotools (NASDAQ: LAB) and Treeline Biosciences, which would leave current shareholders with approximately 16% of the combined entity. Finally, the inquiry includes Rallybio Corporation (NASDAQ: RLYB) regarding its merger with Candid Therapeutics, a deal that projects Rallybio shareholders will retain a 3.65% stake in the resulting company. Shareholders seeking information on these investigations may contact Monteverde & Associates at (212) 971-1341.